Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

733
Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin,...
733
Conjugated Proteins02:50

Conjugated Proteins

29.3K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
29.3K
Viral Structure00:56

Viral Structure

74.8K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
74.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogenesis of Brucella abortus and Brucella melitensis in bovine and ovine-derived trophoblasts and macrophages and impaired intracellular trafficking of the Rev1 vaccine strain.

Veterinary research·2026
Same author

A critical review of diagnostic methods for camel brucellosis.

Veterinary and animal science·2026
Same author

Isolation of luminescent symbiont bacteria from marine cephalopods: a practical activity for the study of bacterial quorum sensing.

FEMS microbiology letters·2026
Same author

Yeast-Derived Postbiotics for Prevention of Enteric Diseases in Farm Animals: Current Insights and Future Perspectives.

Veterinary sciences·2026
Same author

Conjunctival administration of H38ΔwbkF rough vaccine as an effective strategy to protect against Brucella ovis infection while minimizing serological interference.

Veterinary research·2026
Same author

Disruption of the Nitric Oxide Reductase Operon via <i>norD</i> Deletion Does Not Affect <i>Brucella abortus</i> 2308W Virulence.

Microorganisms·2025

Related Experiment Video

Updated: Feb 17, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K

Vaccine development targeting lipopolysaccharide structure modification.

Yun Zhao1, Vilma Arce-Gorvel1, Raquel Conde-Álvarez2

  • 1Centre d'Immunologie de Marseille-Luminy, CIML, Aix Marseille Univ, CNRS, INSERM, Marseille, France.

Microbes and Infection
|December 14, 2017
PubMed
Summary

Structural modification of lipopolysaccharide (LPS) is key for developing effective live attenuated vaccines. This review covers strategies using LPS mutants for whole-cell vaccines to prevent infectious diseases.

Keywords:
BrucellaLipopolysaccharideVaccine

More Related Videos

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.4K
Purification and Visualization of Lipopolysaccharide from Gram-negative Bacteria by Hot Aqueous-phenol Extraction
05:31

Purification and Visualization of Lipopolysaccharide from Gram-negative Bacteria by Hot Aqueous-phenol Extraction

Published on: May 28, 2012

36.8K

Related Experiment Videos

Last Updated: Feb 17, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

3.1K
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.4K
Purification and Visualization of Lipopolysaccharide from Gram-negative Bacteria by Hot Aqueous-phenol Extraction
05:31

Purification and Visualization of Lipopolysaccharide from Gram-negative Bacteria by Hot Aqueous-phenol Extraction

Published on: May 28, 2012

36.8K

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Infectious diseases pose a significant global health challenge.
  • Vaccines are crucial for preventing disease transmission and outbreaks.
  • Lipopolysaccharide (LPS) is a key component of the outer membrane of Gram-negative bacteria.

Purpose of the Study:

  • To review strategies for developing live attenuated vaccines using structural modifications of lipopolysaccharide (LPS).
  • To explore how LPS mutants can be utilized as whole-cell vaccines.
  • To discuss the impact of LPS modification on bacterial immunogenicity and virulence.

Main Methods:

  • Literature review of studies involving LPS mutants in vaccine development.
  • Analysis of different structural modification approaches for LPS.
  • Evaluation of virulence attenuation and immunogenicity enhancement strategies.

Main Results:

  • Structural modification of LPS can alter bacterial immunogenicity.
  • LPS mutants can be effectively used as whole-cell vaccines.
  • Targeted modifications can attenuate bacterial virulence while maintaining protective immunity.

Conclusions:

  • LPS structural modification is a viable strategy for creating novel live attenuated vaccines.
  • Whole-cell vaccines based on LPS mutants offer a promising approach for infectious disease prevention.
  • Further research into LPS engineering can lead to improved vaccine candidates.